Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy.
Andrew E BeaudinCheryl R McCrearyErin L MazerolleMyrlene GeeBreni SharmaArsenije SuboticAngela M ZwiersEmily CoxKrista NellesAnna CharltonRichard FrayneZahinoor IsmailChristian BeaulieuGlen C JicklingRichard M CamicioliGilbert Bruce PikeEric Edward SmithPublished in: Neurology (2022)
Reduced cerebrovascular reactivity is a core feature of CAA and its assessment may provide an additional biomarker for disease severity and cognitive impairment.